PUBLISHER: The Business Research Company | PRODUCT CODE: 1997587
PUBLISHER: The Business Research Company | PRODUCT CODE: 1997587
Cannabigerol (CBG) gummies are edible products infused with cannabigerol, a cannabinoid found in cannabis plants. These gummies typically contain a specific dosage of CBG extract along with other ingredients, offering a tasty and convenient way to consume CBG. They are popular among individuals seeking potential health benefits associated with CBG, such as its anti-inflammatory, neuroprotective, and mood-regulating properties.
The primary categories of CBG gummies include cannabidiol (CBD) edibles and combinations of cannabigerol (CBG) and cannabinol (CBN). Cannabidiol edibles are food products infused with cannabidiol, a compound derived from cannabis known for its potential therapeutic effects. CBG gummies are available in various flavors such as raspberry juice, strawberry juice, cherry juice, strawberry puree, raspberry powder, and others, offered in both hard candy and soft candy forms.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are impacting the cannabigerol gummies market by increasing costs of imported hemp extracts, gelatin alternatives, flavoring agents, packaging materials, and processing equipment. Manufacturers in North America and Europe are most affected due to cross-border sourcing of cannabinoid inputs, while Asia-Pacific faces higher costs for packaging and ingredient imports. These tariffs are increasing product pricing and affecting scalability for smaller brands. However, they are also encouraging domestic hemp cultivation, local extraction facilities, and vertically integrated cannabinoid supply chains.
The cannabigerol (cbg) gummies market research report is one of a series of new reports from The Business Research Company that provides cannabigerol (cbg) gummies market statistics, including cannabigerol (cbg) gummies industry global market size, regional shares, competitors with a cannabigerol (cbg) gummies market share, detailed cannabigerol (cbg) gummies market segments, market trends and opportunities, and any further data you may need to thrive in the cannabigerol (cbg) gummies industry. This cannabigerol (cbg) gummies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cannabigerol (CBG) gummies market size has grown exponentially in recent years. It will grow from $2.94 billion in 2025 to $4.28 billion in 2026 at a compound annual growth rate (CAGR) of 45.3%. The growth in the historic period can be attributed to increasing consumer interest in alternative wellness products, expansion of legal cannabinoid markets, rising awareness of minor cannabinoids, growth of edible-based cannabinoid consumption, improvements in extraction technologies.
The cannabigerol (CBG) gummies market size is expected to see exponential growth in the next few years. It will grow to $15.39 billion in 2030 at a compound annual growth rate (CAGR) of 37.8%. The growth in the forecast period can be attributed to increasing demand for targeted health solutions, expansion of regulated cannabis markets, growing focus on product transparency and labeling, rising investments in cannabinoid research, increasing adoption of gummies as preferred delivery format. Major trends in the forecast period include growing demand for functional cannabinoid edibles, rising popularity of non-psychoactive wellness products, expansion of flavor-infused cbg gummies, increasing focus on precise dosage formats, enhanced emphasis on natural ingredient sourcing.
The increased prevalence of anxiety is expected to propel the growth of the cannabigerol (CBG) gummies market going forward. Anxiety is a psychological condition characterized by persistent feelings of excessive worry, fear, and nervousness, often accompanied by physical symptoms such as restlessness, palpitations, and sweating. The rising prevalence of anxiety is driven by factors such as increasing stress levels, traumatic experiences, genetic predisposition, and environmental and lifestyle influences. Cannabigerol (CBG) gummies are increasingly used by consumers seeking anxiety relief due to CBG's potential interaction with the endocannabinoid system, which may help regulate neurotransmitter activity and promote relaxation and emotional balance. For instance, in February 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, an estimated 2.26 million males (23% of the population) and 3.43 million females (34% of the population) aged 16 to 85 in Australia had experienced an anxiety disorder at some point in their lives. Therefore, the growing prevalence of anxiety is driving demand for CBG-based wellness products, supporting the growth of the CBG gummies market.
Major companies operating in the cannabigerol (CBG) gummies market are focusing on developing innovative formulations, such as gummies made with natural and plant-based ingredients, to meet rising consumer demand for clean-label, wellness-oriented cannabinoid products. Gummies with natural ingredients emphasize organic flavorings, botanical extracts, and minimal synthetic additives, appealing to health-conscious consumers seeking holistic stress and anxiety support. For example, in November 2023, Rare Cannabinoid Company, a U.S.-based health and wellness company, launched THC + CBG Relief Gummies, featuring a unique combination of Delta-9-THC, CBG, and CBD. Each green apple-flavored gummy contains 2.5 mg of Delta-9-THC, 30 mg of CBG, and 10 mg of CBD, offering a balanced formulation designed to support relaxation and physical well-being through natural cannabinoid synergy. This launch reflects the market's shift toward multifunctional, carefully dosed cannabinoid edibles that align with wellness and mental health trends.
In October 2024, Canopy Growth Corporation, a Canada-based cannabis company, acquired Wana for an undisclosed amount. Through this acquisition, Canopy USA aims to expand its presence in the U.S. market and strengthen its hemp-derived and state-legal edibles portfolio. Wana is a U.S.-based cannabis company known for its innovative edible and ready-to-drink products, including Delta-9-THC and non-intoxicating CBD gummies. This acquisition supports Canopy Growth's strategy to broaden its cannabinoid product offerings and capitalize on growing consumer demand for functional, wellness-focused edibles such as CBG gummies.
Major companies operating in the cannabigerol (CBG) gummies market are Demetrix Inc., Rare Cannabinoid Company, CanniLabs, Vida Optima LLC, Curaleaf Holding Inc., The Cronos Group, Charlotte's Web Holdings Inc., Hemptown USA Inc., Green Roads LLC, Lazarus Naturals Inc., Medterra CBD LLC, ENDOCA, Extract Labs, NuLeaf Naturals LLC, Isodiol International Inc., CBDistillery, Elixinol Wellness Ltd., Joy Organics, CBD American Shaman, Steves Goods, Incredibles Edibles, Sunday Scaries, CannaCare Health GmbH, FAB Nutrition LLC (FAB CBD)
North America was the largest region in the cannabigerol (CBG) gummies market in 2025. The regions covered in the cannabigerol (CBG) gummies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cannabigerol (CBG) gummies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The cannabigerol (CBG) gummies market consists of sales of pure CBG gummies, broad spectrum CBG gummies, full spectrum CBG gummies, isolate CBG gummies, and CBG-infused gummies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cannabigerol (CBG) Gummies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cannabigerol (cbg) gummies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cannabigerol (cbg) gummies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cannabigerol (cbg) gummies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.